SERV Behavioral Health System Inc SERV Centers of NJ Inc
-
Services:
- Vaping permitted in designated area
- Motivational interviewing
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Relapse prevention
- Substance use disorder counseling
- Trauma-related counseling
- Brief intervention
- Naloxone and overdose education
- Aftercare/continuing care
- Outcome follow-up after discharge
- Discharge Planning
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Intensive outpatient treatment
- Regular outpatient treatment
- Outpatient detoxification
- Other contracted prescribing entity
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Prescribes buprenorphine
- Lofexidine or Clonidine detoxification
- Federally-certified Opioid Treatment Program
- Buprenorphine detoxification
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Clients with co-occurring mental and substance use disorders
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- This facility administers/prescribes medication for alcohol use disorder
- SAMHSA certification for opioid treatment program (OTP)
- State department of health
- Mentoring/peer support
- Assistance with obtaining social services
- Housing services
- Recovery coach
- Employment counseling or training
- Payment assistance (check with facility for details)
- Screening for substance use
- Outreach to persons in the community
- Complete medical history/physical exam
- Screening for mental disorders
- Comprehensive substance use assessment
- Screening for tobacco use
- Comprehensive mental health assessment
- Buprenorphine (extended-release, injectable)
- Clonidine
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Acamprosate (CampralĀ®)
- Naltrexone (oral)
- Buprenorphine with naloxone
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Private non-profit organization
- Male
- Female
- Case management service
- Suicide prevention services
- Early intervention for HIV
- Social skills development
- Integrated primary care services
- Transportation assistance
- Mental health services
- Other languages (excluding Spanish)
- Sign language services for the deaf and hard of hearing
- Cash or self-payment
- Medicaid
- Federal, or any government funding for substance use treatment programs
- SAMHSA funding/block grants
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Family counseling
- Individual counseling
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Marital/couples counseling
- Smoking permitted in designated area
- Metabolic syndrome monitoring
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- STD testing
- TB screening
- HIV testing
- Breathalyzer or blood alcohol testing
- Creole
- Adults
- Young Adults
Facility Vaping Policy
Treatment Approaches
Transitional Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Opioid Treatment
Special Programs/Groups Offered
Opioid Medications used in Treatment
Type of Care
Detoxification (medical withdrawal) Services
Type of Alcohol Use Disorder Treatment
License/Certification/Accreditation
Recovery Support Services
Payment Assistance Available
Assessment/Pre-treatment
Pharmacotherapies
Facility Operation (e.g., Private, Public)
Gender Accepted
Ancillary Services
Language Services
Payment/Insurance/Funding Accepted
Education and Counseling Services
Facility Smoking Policy
Testing
Other Languages
Age Groups Accepted